Christine M. Eischen

Thomas Jefferson University

NIH Rank #5295
  • Program Leader
  • R01 Holder
  • Early Career

NIH Funding · FY2024

Total Funding
$2M
Fiscal year 2024
Grants Awarded
5
Active NIH grants
National Rank
#5,295
Among 57,894 PIs
First NIH Award
2024
Year of first funding

Funding & rank history

NIH funding totals and national rank by fiscal year.

Single fiscal year on record (FY2024): $2M across 5 grants · National rank #5295.

Top grants by award amount

Christine M. Eischen's NIH grant portfolio, ranked by award amount.

  • 1R01CA279364-01A1R01
    A Next-Generation Nucleoside Prodrug for Diffuse Large B-Cell Lymphoma
    $623.6K
    award amount
  • 5R01CA272645-03R01
    Design of the First Mdm2 Targeting PROTACs for treatment of p53 Mutant or Deficient Cancers
    $515.2K
    award amount
  • 5R01DE033025-02R01
    Investigating a new vulnerability in oral squamous cell carcinoma
    $511.5K
    award amount
  • 5R01CA236853-05R01
    BCLW in lymphoma survival and resistance to targeted BCL2 family therapies
    $355.2K
    award amount
  • 2P30CA056036-24P30
    Translational Research in Cancer
    $1
    award amount

Affiliations

Institutions that have administered grants for Christine M. Eischen.

Career milestones

Key NIH funding milestones over time.

  1. 2024
    First NIH Award
    Thomas Jefferson University
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2024
    $2M Cumulative Funding
  5. 2024
    Entered Top 50% Nationally
    Ranked #5295
  6. 2024
    Multi-Institutional Research
    Awards at 2 institutions